CBUS

Cibus, Inc. Class A Common Stock

$1.40

Current Price

All

AI analysis

Read what the AI thinks of Cibus, Inc. Class A Common Stock in the app.

Analyses are generated by AI from public data and are not investment advice.

Get the app

Key figures

Dividend per share

—

Yield

—

EPS

-$1.65

P/E

—

Data as of Oct 1

Why it matters for the long term

Over 10-20 years, what drives a share up is the growth of its profits (EPS) + reinvested dividends. The P/E tells you whether you are paying a lot or a little for that growth. In short: rising EPS + reasonable P/E + growing dividend = good long-term candidate.

Upcoming events

Quarterly earnings

Expected EPS: -$0.28

Nov 5

Posts

No posts about CBUS yet.

About Cibus, Inc. Class A Common Stock

Cibus is a small US biotechnology company that develops gene-editing tools for farming. It aims to create crops that resist disease and pests, and it plans to earn money by licensing those traits and sharing in the value they create. Revenue is still tiny, so the company is an early-stage research bet rather than an established business.